1996
DOI: 10.1007/bf00131082
|View full text |Cite
|
Sign up to set email alerts
|

Pharmaceutical applications of peptidomimetics

Abstract: Nature has used a 'library approach' to constructing ligands for specific receptors and enzymes by combining a limited functional diversity of 20 amino acid side chains with a small array of secondary structure motifs -reverse turns, co-helices and [3-strands. The dissection of multidomain proteins into small synthetic conformationally restricted components is an important step in the design of low-molecular-weight nonpeptides that mimic the activity of the native protein. Mimetics of critical functional domai… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

1998
1998
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 22 publications
0
3
0
Order By: Relevance
“…Strategies are being developed for the structure-guided design of mimetics of lead peptides, and there have been some successes reported (27)(28)(29). Notable advances include the substitution of thioether bonds in place of disulfides (28,30) and the use of R-methyl proline to stabilize turns.…”
mentioning
confidence: 99%
“…Strategies are being developed for the structure-guided design of mimetics of lead peptides, and there have been some successes reported (27)(28)(29). Notable advances include the substitution of thioether bonds in place of disulfides (28,30) and the use of R-methyl proline to stabilize turns.…”
mentioning
confidence: 99%
“…For example, the erythropoietin (EPO) mimetic identified from phage display do not have any homology with EPO, but able to mimic the hormone function [100]. In recent years, there has been a significant progress in the field of peptide chemistry and now peptide mimetics can be used as a template, and through iterations that reduce size and increase biological activity, may lead to viable therapeutic reagents [3,41,42,43,48,96,101,102,103,104,105,106,107,108,109]. …”
Section: Structure Of Immunoglobulinmentioning
confidence: 99%
“…In some cases, this strategy led to the production of analogues with advantageous biological and functional properties. The generation of structural mimics related to neuropeptides, peptide hormones, peptide antibiotics, or more recently peptides with potential use in vaccination has thus attracted considerable attention ( ). The modifications introduced into peptides are for example the replacement of l -amino acid by d -amino acid residues or by unnatural ones and/or the modification of peptide bonds.…”
mentioning
confidence: 99%